
This paper highlights considerations based on risk that ensure ongoing success as well as improvement when applying cleaning and decontamination principles for biopharmaceutical cleanroom surfaces.
Donald Singer is senior global microbiology consultant with New Beginnings Microbiology, a Fellow in the American Society for Quality, and formerly with Ecolab Life Sciences.
This paper highlights considerations based on risk that ensure ongoing success as well as improvement when applying cleaning and decontamination principles for biopharmaceutical cleanroom surfaces.
Subsequent guidance and manufacturing realities make portions of USP Chapters <62 >and <111> significantly less relevant. The authors suggest formal chapter revisions.
Published: October 21st 2020 | Updated: